FAQs | Site Map | Links | Home
January 13, 2009
skip navigation

  arrow Bill Tracking

  (spacer) Legislative Updates

  (spacer) Public Laws

  (spacer) Hearings

  (spacer) Committees of
   (spacer) Interest to NIH


  (spacer) OLPA


margin frame

Bill TrackingBill Tracking
(spacer)

House Bills - 108th Congress

arrow indicating current page Session I | Session II

H.R. 373—Robin Danielson Act

On January 27, 2003, Representative Carolyn Maloney (D-NY) introduced H.R. 373, the Robin Danielson Act. The bill would establish 1) a program of research regarding the risks posed by the presence of dioxin, synthetic fibers, and other additives in feminine hygiene products, and 2) a program for the collection and analysis of data on toxic shock syndrome. Specifically, the bill would require the Director of NIH, in collaboration with the Director of ORWH, to provide for research to determine the extent to whether these additives pose any risk to the health of women or the health of their children. Reports on the research must be submitted periodically to Congress, FDA, EPA, the Consumer Product Safety Commission, and the public. The bill was referred to the House Energy and Commerce Subcommittee on Health.

Legislative Update (December 2003): Women's Health

(spacer)

 

Privacy | Accessibility | Disclaimer    

National Institutes of Health Department of Health and Human Services USA.gov - Government Made Easy